Type 2 diabetes mellitus (T2DM) has become a global public health issue encompassing even children and youth in recent decades. It is a complex disease influenced by genetic and environmental factors. Although much attention is paid to environmental factors since they are identifiable and potentially modifiable, beginning the turn of the 21st century, there has been an explosion of activities that are aimed to screen the genome for identifying T2DM susceptibility genes. This gained momentum with a confluence of different scientific disciplines that was showcased by the millennial Human Genome Project and its aftermath. Currently, the next generation sequencing accelerated the identification of potential causal genes/variants (especially low frequency and rare variants) influencing complex diseases such as T2DM. Also, the other technologies such as transcriptomics, proteomics, metabolomics and epigenomics have emerged as additional tools to identify the molecular factors underling the phenotypic expression of T2DM. The voluminous biological data generated by these studies has necessitated or contributed to bioinformatics, a confluence of biology and its various flavours, information technology, computational biology, algorithms, matching, statistics, mathematics, nanotechnology, ethics among others.
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The areas of analysis using bioinformatics in diabetes can be approached as employing datasets from genome or amino acid sequences, structures of biological molecules and functional genomics experiments. Nevertheless analyses extend to other types of data including evolutionary trees, metabolic pathways and the semantics of published literature.
Mathematical models and analysis and statistical analyses are required to obtain critical information from the large amounts of data that is generated by genomic and other approaches. Newer algorithms to cluster data from a wide scatter will be relevant: for example, K-means can select best density in a self-adoptive manner and initialize r empirically; an improved method over K means, the Automatic Generation of Distance for Density based Clustering (AGDDC) was developed by Karteeka Pavan et al. to optimize number of clusters [1] . This was developed to find initial optimum centroids based on density clustering. It can be applied to relevant genes related to the pathogenesis of T2DM.
The challenge in modern biology and of modern diabetes, is a profusion of data. Bioinformatic methods aid in curating and synthesizing the deluge [2] . The Human Genomics Project (HGP) which heralded the situation where data overran the capacity to cull out the information, simultaneously saw sequencing of genes of other species including vertebrates, invertebrates, fungi, bacteria and plants. The underlying theme was to know how genetic architecture and genes evolved over time. Considering that the basic building blocks were the four nucleotides across all life forms, it was logical to compare the genomes of different species to identify where and how divergence of genes occurred and how newer metabolic pathways emerged [3, 4] .
The initial steps in using bioinformatics techniques in diabetes consisted of identifying known genes from literature and from genomic databases that were related to different aspects of diabetes or its complications. Phylogenetic trees were then constructed using the nucleotide or amino acid sequences and giving scores of relatedness. Based on these, their putative role in complications were reconstructed and compared with similar results obtained by other methods. In this way, for diabetic neuropathy, sequences with minimum distance were nerve growth factor beta polypeptide, aldose reductase, Na+-K+-ATPase, C-peptide, poly (ADP-ribose) polymerase PARP [5] . Similarly aldose reductase and nitric oxide synthase were shown to be associated with diabetic retinopathy, suggesting they may do so by modulating aldose reductase and nitric oxide synthase [6] . Employing multiple sequence alignment using ClustalW to construct a phylogenetic tree, a causal relationship was suggested between altered calcium homeostasis and diabetic cardiomyopathy [7] .
Hypothesis generation about pathogenesis of diabetes is possible using phylogenetic models: scores of multiple sequence alignment of bone derived nuclear factor (BDNF), insulin, leptin, ghrelin, C reactive protein sequences exhibited a potential association among insulin, ghrelin, leptin, melanocortin, CRP, and BDNF suggesting they could have a pathogenetic role in obesity and type 2 diabetes mellitus [8] . It is also possible to apply data mining and mathematical computational methods to identify which species contain proteins related to diabetes. For example, we reported that they were present in Human Beings, House Mice and Norway Rat [9] .
Regarding T2DM and its related traits, numerous studies have reported genetic contributions, ranging from simple heritability estimates to mapping of susceptibility genes using genome-wide linkage and association approaches, to phenotypic manifestations such as carotid artery wall thickness [10] , glucose concentrations [11] , insulin resistance [12] , T2DM [13, 14] , renal function [15] , lipids [16, 19] , obesity [17] , retinopathy [18] , systolic blood pressure [20] and metabolic syndrome and cardio-metabolic risk factors in children and adolescents [21] . Specifically, the recent GWASs have contributed greatly to an understanding of the complex genetic architectures of T2DM and its related traits. There have been numerous successes in localization of susceptibility genes/variants for common complex diseases including T2DM, obesity, and MS, using the genome-wide association study (GWAS) approach [22] [23] [24] [25] [26] [27] [28] . However, the contribution of common variants identified by the GWASs to the overall genetic susceptibility to T2DM or its related traits such as obesity is modest [i.e., missing heritability] [29, 30] , and that knowledge on the actual causal genes/variants influencing T2DM or its related traits is very limited. Most of the GWASs were conducted using large population-and case-controlbased data sets from Europeans or populations with European ancestry, and there have been efforts to replicate the original association findings or to find new association signals in ethnically diverse populations [31] [32] [33] As reviewed by Sanghera and Blackett [31] , the GWASs have localized and replicated about 75 susceptibility loci associated with T2DM and its related metabolic traits. Data from Asian cohorts that included subjects from India were published recently [34] [35] [36] . In addition, hypothesis generating reports have also been published based on network analysis [37] . With widespread availability of sequence data, it is possible to do further analysis using information that is available on supplementary tables from published articles [38] . Similarly, innovative genetic studies employing extremes of blood pressure levels have identified newer genetic loci such as UMOD locus for hypertension which may be potential targets for drug development [39] . Similar to genetic risk score assessment, a score for predicting hypertension has also been proposed [40, 41] . Merging of all scattered scores can perhaps give a comprehensive risk assessment.
The current issue of the Journal provides a flavour of genetic association studies with diabetes that are being carried out. A broad spectrum of data is showcased on a variety of phenotype and genotype correlations. With diabetes being at the forefront of research, it would be fruitful to form consortia from different geographic areas of India where DNA samples are collected and stored, along with a detailed phenotypic description of each study participant. The latter is extremely important because modern technology allows identification of genetic structure and variation. To make sense in clinical terms requires one to have phenotypic information with which to correlate. Otherwise studies would be intellectual challenges without being applicable to real world. The time to embark on large consortia of susceptibility gene discovery studies is now.
